Canada should have a national pharmacare program that is universal, single payer and public, says an advisory council tasked with studying the possibility.
The Advisory Council on the Implementation of National Pharmacare made this statement in its final report, released Wednesday morning. The council, which was asked last June to look into the issue, says this kind of program will result in better drug coverage for Canadians and save individuals and governments money.
Full article at: Global News